Principal Institute Research Scientist, Rezvani LabThe University of Texas MD Anderson Cancer CenterHouston, Texas, United States
CAR Therapies: Beyond T-cells and CD19 as the Target
Monday, September 15, 202510:45 - 11:00 CEST